Emerging therapeutic targets in the short QT syndrome

Hancox, JC, Whittaker, DG orcid.org/0000-0002-2757-5491, Du, C et al. (2 more authors) (2018) Emerging therapeutic targets in the short QT syndrome. Expert opinion on therapeutic targets, 22 (5). pp. 439-451. ISSN 1472-8222



Copyright, Publisher and Additional Information: © 2018 Informa UK Limited, trading as Taylor & Francis Group. This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Opinion on Therapeutic Targets on 26 April 2018, available online: http://www.tandfonline.com/10.1080/14728222.2018.1470621. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Atrial fibrillation, atrial-selective, CACNA1C, CACNA2D1 CACNB2b hERG, KCNH2, KCNJ2, KCNQ1, Kir2.1, short QT syndrome, SLC4A3, sudden death, ventricular fibrillation
  • Accepted: 25 April 2018
  • Published (online): 26 April 2018
  • Published: 4 May 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Biological Sciences (Leeds) > School of Biomedical Sciences (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 09 May 2018 13:32
Last Modified: 26 Apr 2019 00:39
Status: Published
Publisher: Taylor & Francis
Identification Number: https://doi.org/10.1080/14728222.2018.1470621